Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acthar Gel in active anterior uveitis
NCT02769702Phase 4Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Jun 2016
- Primary completion
- Jan 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of repository corticotropin injection in anterior uveitis (AU), sponsored by Washington University School of Medicine. Started Jun 2016; status: terminated.
02
Drugs
repository corticotropin injection
03
Conditions
anterior uveitis (AU)
Beyond the preview
Go deeper on NCT02769702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02769702.